3.54
前日終値:
$3.48
開ける:
$3.51
24時間の取引高:
253.96K
Relative Volume:
0.37
時価総額:
$356.12M
収益:
-
当期純損益:
$-60.14M
株価収益率:
-4.9894
EPS:
-0.7095
ネットキャッシュフロー:
$-68.17M
1週間 パフォーマンス:
+6.63%
1か月 パフォーマンス:
+13.10%
6か月 パフォーマンス:
+45.68%
1年 パフォーマンス:
+33.08%
Ac Immune Sa Stock (ACIU) Company Profile
ACIU を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
ACIU
Ac Immune Sa
|
3.54 | 350.09M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-05-31 | 開始されました | BTIG Research | Buy |
| 2019-02-01 | ダウングレード | UBS | Buy → Neutral |
| 2019-01-04 | 開始されました | UBS | Buy |
| 2018-04-05 | 開始されました | H.C. Wainwright | Buy |
| 2018-03-23 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | 開始されました | Credit Suisse | Outperform |
| 2016-10-18 | 開始されました | Jefferies | Buy |
| 2016-10-18 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Ac Immune Sa (ACIU) 最新ニュース
Performance Recap: Is Stagwell Inc stock forming a cup and handleGDP Growth & Low Risk High Win Rate Picks - baoquankhu1.vn
Dip Buying: Should I buy AC Immune SA stock nowJuly 2025 Opening Moves & Fast Gain Swing Alerts - baoquankhu1.vn
Will AC Immune SA outperform the market in YEAR2025 Key Highlights & High Win Rate Trade Alerts - mfd.ru
AC Immune (NASDAQ:ACIU) Stock Price Down 5.4%Time to Sell? - MarketBeat
Profit Recap: Will AC Immune SA outperform its industry peersIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn
What is AC Immune SA s revenue forecastSmall Cap Stock Opportunities & Learn to Pick Stocks in Under 10 Minutes - bollywoodhelpline.com
Aug Outlook: Will AC Immune SA outperform its industry peersStock Surge & Real-Time Volume Analysis - baoquankhu1.vn
Fed Meeting: Will AC Immune SA outperform its industry peers2025 Market Sentiment & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Risk Off: Why AC Immune SA stock attracts global investors2025 Bull vs Bear & Verified Chart Pattern Trade Signals - Bộ Nội Vụ
Top Penny Stocks To Watch In January 2026 - Yahoo Finance
Trading Recap: Can AC Immune SA stock deliver surprise earnings beatEarnings Overview Report & AI Based Buy/Sell Signal Reports - Bộ Nội Vụ
What insider purchases suggest about AC Immune SA (IMR) stockJuly 2025 Breakouts & Growth Focused Stock Reports - Улправда
What valuation ratios show for AC Immune SA (IMR) stockJuly 2025 Final Week & Weekly High Potential Alerts - Улправда
How AC Immune SA stock benefits from tech adoption2025 Price Targets & Long Hold Capital Preservation Plans - Улправда
How AC Immune SA stock performs after earningsNew Guidance & Expert-Curated Trade Recommendations - ulpravda.ru
Can AC Immune SA stock beat market expectations this quarterMarket Growth Summary & Fast Entry Momentum Trade Alerts - Улправда
Will AC Immune SA stock split again soon2025 EndofYear Setup & Short-Term Trading Alerts - ulpravda.ru
Risk Check: What hedge fund activity signals for AC Immune SA stock2025 Year in Review & Verified Technical Signals - Улправда
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results - MSN
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week - Yahoo Finance
Why is AC Immune stock up over 23% today? - MSN
Short Interest in AC Immune (NASDAQ:ACIU) Grows By 94.4% - MarketBeat
Assenagon Asset Management S.A. Purchases New Position in AC Immune $ACIU - Defense World
Market Leaders: Will AC Immune SA stock split again soonMarket Trend Review & High Return Stock Watch Alerts - moha.gov.vn
AC Immune (STU:IMR) EV-to-OCF : -3.79 (As of Jan. 06, 2026) - GuruFocus
AC Immune (NASDAQ:ACIU) Trading Up 5%Should You Buy? - MarketBeat
Why ETFs are accumulating AC Immune SA (IMR) stockTechnical Breakout Signals & Free High Impact Stock Picks - bollywoodhelpline.com
Why AC Immune SA stock remains a top recommendationPortfolio Value Report & Real-Time Stock Entry Alerts - Улправда
New Highs: Will AC Immune SA stock recover faster than marketWeekly Investment Summary & Real-Time Volume Trigger Notifications - Улправда
How AC Immune SA stock responds to policy changesPortfolio Return Report & Daily Profit Maximizing Tips - Улправда
Why analysts upgrade AC Immune SA stock2025 Year in Review & AI Enhanced Market Trend Forecasts - Улправда
Will AC Immune SA (IMR) stock boost dividends further2025 EndofYear Setup & Safe Capital Preservation Plans - DonanımHaber
Should I hold or sell AC Immune SA stock in 2025Market Performance Report & Consistent Income Trade Recommendations - DonanımHaber
Is AC Immune SA stock supported by strong fundamentals2025 Bull vs Bear & Free Community Consensus Stock Picks - Bölüm Sonu Canavarı
Recap Report: Why analysts upgrade AC Immune SA stockWeekly Investment Summary & Growth Oriented Trading Recommendations - ulpravda.ru
Will AC Immune SA stock outperform Dow Jones indexPortfolio Update Report & Reliable Entry Point Alerts - ulpravda.ru
Aug Update: Will AC Immune SA stock recover faster than market2025 Market Sentiment & Safe Capital Allocation Plans - Улправда
AC Immune (STU:IMR) OCF Margin % : -1,953.03% (As of Sep. 2025) - GuruFocus
AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD - Seeking Alpha
AC Immune SA (ACIU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Performance Recap: Will AC Immune SA stock outperform growth indexesJuly 2025 News Drivers & AI Powered Trade Plan Recommendations - moha.gov.vn
Aug Macro: Will AC Immune SA IMR stock outperform value peers2025 Technical Overview & Precise Swing Trade Alerts - moha.gov.vn
AC Immune Perks Up On Positive Parkinson’s Data - Citeline News & Insights
AC Immune reports promising phase 2 results for Parkinson’s therapy - MSN
AC Immune’s Parkinson’s vaccine advances on promising biomarker profile - BioCentury
AC Immune Simulates Curiosity in Neurodegenerative Fight with Global Conference Plans - StocksToTrade
AC Immune (ACIU) Stock: Surges as ACI-7104.056 Shows Potential in Early Parkinson’s Disease - parameter.io
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - Benzinga
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results - TipRanks
Ac Immune Sa (ACIU) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):